Cyclical Etidronate in the Treatment of Postmenopausal Osteoporosis: Efficacy and Safety After Seven Years of Treatment
- 31 December 1997
- journal article
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 103 (6), 468-476
- https://doi.org/10.1016/s0002-9343(97)00278-7
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple MyelomaThe New England Journal of Medicine, 1996
- Cyclical edidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosisAmerican Journal Of Medicine, 1995
- Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal womenAmerican Journal Of Medicine, 1995
- INTERMITTENT CYCLICAL ETIDRONATE IN THE PREVENTION OF CORTICOSTEROID-INDUCED BONE LOSSRheumatology, 1994
- Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: Three years of blinded therapy followed by one year of open therapyAmerican Journal Of Medicine, 1993
- Vertebral fracture assessment using a semiquantitative techniqueJournal of Bone and Mineral Research, 1993
- Bisphosphonates act on rat bone resorption through the mediation of osteoblasts.JCI Insight, 1993
- Intermittent Cyclical Etidronate Treatment of Postmenopausal OsteoporosisThe New England Journal of Medicine, 1990
- Prevention of glucocorticoid-induced osteoporosisJournal of Bone and Mineral Research, 1990
- Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal OsteoporosisThe New England Journal of Medicine, 1990